
Teenager vows to ‘resist' any weakening of six-month timeframe for assessments
The Government has 'systematically smashed' disability laws on important checks for children, a teenage campaigner has told the Oireachtas.
Cara Darmody, 14, addressed the Oireachtas Disability Committee on Wednesday about the backlog in the assessment of need (AON) system.
Advertisement
An AON is carried out to identify if a child, children or young person has a disability, and is designed to identify their health needs as well as service requirements.
Once the HSE receives an application, there is a legal requirement for the AON to be completed within six months.
On the possibility of changes to the laws being in train, Cara said she would 'vigorously resist any negative change' to the six-month timeframe, saying she believed it would cause 'further permanent damage to children'.
The total number of applications overdue for completion at the end of March 2025 stood at 15,296, an 8% rise on the end of 2024.
Advertisement
Throughout the first quarter of this year, just 7% of assessments were completed within the timeframes set out in the Disability Act 2005 and accompanying regulations.
The HSE said that demand for AONs continues to outstrip system capacity, despite increases in activity and commissions from private assessors.
The health service anticipates that by the end of the year there could be as many as 24,796 AONs due for completion.
Opposition parties including Sinn Fein, Labour, Social Democrats, People Before Profit-Solidarity, Independent Ireland and Aontu have supported Cara's campaign.
Advertisement
Last month she staged a 50-hour protest outside Leinster House.
She was initially motivated to pursue her advocacy because her two brothers have autism and severe/profound intellectual disabilities.
Speaking at Committee, Cara said: 'My own story is very simple, I have two brothers Neil, 12, and John, eight, who are autistic and severely and profoundly intellectually disabled.
'They were both failed dramatically by the state in relation to assessments and services, and Neil remains in an inappropriate school place.
Advertisement
'Our story is the story of so many thousands of other families. I cannot do anything to change the permanent damage caused to Neil and John, but I can advocate to stop damage being done to autistic children in the future.'
She said Taoiseach Micheál Martin and the wider Government are breaking the law over the delivery of AONs.
'Three different taoisigh have made promises to me to fix this issue, and all have dramatically failed.'
She added: 'Let me explain how they're breaking the law. The Disability Act of 2005, an Act created by this House, states that an assessment of need must be carried out within six months, full-stop.
Advertisement
'That six-month timeframe is there because every single person knows that early intervention is the key.
'It's also generally accepted that when early intervention doesn't occur, that damage is caused to children with disabilities. It's a no-brainer.'
Cara said she was shocked that Mr Martin would not declare a national emergency over the matter.
She said the taoiseach should also set up a taskforce to address the matter, and increase financing for 'Cara's Fund'.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BBC News
2 hours ago
- BBC News
Cancer: World-first 'Trojan horse' therapy to be given on NHS
A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world can halt the blood cancer myeloma for nearly three times longer than current drug is an advanced form of chemotherapy that hits cancer with a bigger dose, while reducing Silvester, one of the first people to get it, says the therapy has been "life-changing" and he's now planning history-themed adventures. Myeloma – also known as multiple myeloma – affects part of the immune system called plasma cells. These are made in the spongey bone marrow in the centre of our who is 60 and from Sheffield, was diagnosed nearly two years ago after the cancer led to broken bones in his had a bone marrow transplant last year, but relapsed around Christmas. He has since been on the new therapy – called belantamab mafodotin – as part of an early access weeks he was in remission. Other treatments could have left him isolating in his bedroom for months, so Paul says the therapy "is absolutely life-changing" and was "creating that opportunity to enjoy" life. Visiting Hadrian's Wall is next on the agenda for history buff Paul; and he's looking forward to one of his daughters graduating later this year. "Most people say 'you look really really well'... I have a good normal life," he told the BBC. How does this therapy work? Paul's therapy - belantamab mafodotin – is a lethal chemotherapy drug that has been bound to an antibody, similar to the ones the body uses to fight infection. However, these antibodies have been designed to spot markings on the outside of plasma cells. So they travel to cancerous cells, stick to the surface and are then absorbed. Once inside they release their toxic payload, to kill the cancer. The therapy is named Trojan horse therapy after the siege of the city of Troy in Greek mythology, when a giant wooden horse was used to smuggle soldiers into the cannot be cured, but clinical trials last year showed the Trojan horse therapy halted the cancer for three years, compared to 13 months with current therapies. Prof Peter Johnson, the national clinical director for cancer at NHS England, said the difference was "life-changing".He told me: "This is a really important development for people with myeloma, because although we may not be able to cure the illness, giving them time free of the disease and free of the symptoms is really important."We've seen in the last few years that using antibodies to deliver chemotherapy drugs directly into cells can make a big difference for a variety of different types of cancer." Around 33,000 people are living with myeloma in the UK. The new drug will be used when the first-choice therapy fails, so around 1,500 patients a year could decision comes after a review by the National Institute of Health and Care Excellence (NICE) concluded the drug was cost-effective for NHS use. NICE recommendations are normally adopted in England, Wales and Northern Ireland while Scotland has its own process. The therapy is kinder than other cancer treatments, but is not free from side-effects. After a cancer cell has been destroyed, the remaining chemotherapy drug will leak into the body. This can cause dry eyes and blurred vision. 'These are very smart drugs' The technical name for these drugs is an therapy was developed by GSK in the UK with early research taking place in Stevenage and the first clinical trials in Martin Kaiser, team leader in myeloma molecular therapy at the Institute of Cancer Research, said these "are very smart drugs" and the difference in side effects compared to other drugs "is really remarkable".While myeloma is still considered an incurable cancer, Prof Kaiser says drugs like this are "an important step towards a functional cure" and he thinks long-term remission will go "above 50% in the next five years".Antibody drug conjugates are being developed for a range of cancers. The limitation is being able to design an antibody that can target the cancer alone. There is one that can target some types of breast cancer. Research is already taking place on stomach and bowel McKinlay, from the charity Myeloma UK, said the approval would "transform the lives of thousands" and it was "fantastic to see the UK at the forefront of myeloma treatment".Health Minister Karin Smyth, said: "This ground-breaking therapy puts the NHS at the forefront of cancer innovation."


Reuters
3 hours ago
- Reuters
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults
June 12 (Reuters) - The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's (MRNA.O), opens new tab respiratory syncytial virus vaccine to a lower group of high-risk adults aged 18 to 59 years.


Daily Mail
3 hours ago
- Daily Mail
EXCLUSIVE 'Holy grail' cancer therapy gives terminally ill men new hope in major breakthrough
A groundbreaking cancer treatment hailed as a 'holy grail' is offering fresh hope to patients previously given just months to live. A new study in California looked at 15 men who were 'knocking on death's door' due to late-stage prostate cancer like the one suffered by former president Joe Biden. Your browser does not support iframes.